These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
987 related articles for article (PubMed ID: 28825310)
1. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI. Kim YN; Song JS; Moon WS; Hwang HP; Kim YK Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310 [TBL] [Abstract][Full Text] [Related]
2. LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI. Song JS; Choi EJ; Hwang SB; Hwang HP; Choi H Eur Radiol; 2019 Jan; 29(1):401-410. PubMed ID: 29922928 [TBL] [Abstract][Full Text] [Related]
3. Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017). Ding Y; Rao SX; Wang WT; Chen CZ; Li RC; Zeng M Cancer Imaging; 2018 Dec; 18(1):48. PubMed ID: 30526674 [TBL] [Abstract][Full Text] [Related]
4. Imaging Features of Hepatocellular Carcinoma: Quantitative and Qualitative Comparison Between MRI-Enhanced With Gd-EOB-DTPA and Gd-DTPA. Son J; Hwang SH; Park S; Han K; Chung YE; Choi JY; Kim MJ; Park MS Invest Radiol; 2019 Aug; 54(8):494-499. PubMed ID: 31094878 [TBL] [Abstract][Full Text] [Related]
5. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine. Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455 [TBL] [Abstract][Full Text] [Related]
6. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242 [TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v. Yao WW; Zhang HW; M YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F Technol Cancer Res Treat; 2024; 23():15330338241260331. PubMed ID: 38860337 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid. Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837 [TBL] [Abstract][Full Text] [Related]
10. Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features? Joo I; Lee JM; Lee DH; Jeon JH; Han JK Eur Radiol; 2019 Apr; 29(4):1724-1732. PubMed ID: 30255250 [TBL] [Abstract][Full Text] [Related]
11. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study. Kim SS; Kim SH; Song KD; Choi SY; Heo NH J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483 [TBL] [Abstract][Full Text] [Related]
12. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography. Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948 [TBL] [Abstract][Full Text] [Related]
13. Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria. Rhee H; Kim MJ; Park YN; Choi JS; Kim KS J Magn Reson Imaging; 2012 Feb; 35(2):393-8. PubMed ID: 21990116 [TBL] [Abstract][Full Text] [Related]
14. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022 [TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis. Liu X; Jiang H; Chen J; Zhou Y; Huang Z; Song B Liver Transpl; 2017 Dec; 23(12):1505-1518. PubMed ID: 28886231 [TBL] [Abstract][Full Text] [Related]
16. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies. Li J; Wang J; Lei L; Yuan G; He S Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172 [TBL] [Abstract][Full Text] [Related]
17. Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis. Pan J; Li W; Gu L; Liu C; Zhang K; Hong G Eur Radiol; 2022 Nov; 32(11):7883-7895. PubMed ID: 35579711 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma. Yao WW; Zhang HW; Ma YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F Abdom Radiol (NY); 2024 Jul; 49(7):2242-2249. PubMed ID: 38824474 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270 [TBL] [Abstract][Full Text] [Related]
20. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma. Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]